Model Number 9-PFO-025 |
Device Problem
Biocompatibility (2886)
|
Patient Problems
Arrhythmia (1721); Dyspnea (1816); Nausea (1970); Thrombosis/Thrombus (4440)
|
Event Date 05/01/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
The results, method, and conclusion codes along with investigation results will be provided in the final report.
|
|
Event Description
|
Clinical study: patient id: (b)(6).It was reported that on (b)(6) 2021, a 25 mm amplatzer pfo occluder was successfully implanted in a patient with preexisting conditions of tachycardia.Post-implant the patient was noted to have bleeding issues.On (b)(6) 2021, a hematoma was noted under the incision site with increasing pain.Ultrasound was performed and it was noted not to be a pressing issue.The hematoma later self-resolved on (b)(6) 2021.On (b)(6) 2021, an echocardiogram was performed and revealed a small mobile thrombus on the right atrial side of the implanted device.No intervention was performed and the thrombus was noted to have disappeared on (b)(6) 2021.On (b)(6) 2021, the patient had nausea, palpitations, and shortness of breath while driving.The patient presented to the emergency department and was diagnosed with tachycardia.The patient was given ondansetron orally and the symptoms resolved.The patient was discharged without being admitted to the hospital.There is no allegation that the cause of the tachycardia was due to the abbott device or implant procedure.No additional information was reported.
|
|
Manufacturer Narrative
|
An event of thrombus on the device, which self-resolved was reported.A more comprehensive assessment could not be performed, as the device remains implanted.Was not returned for analysis.The device history record was reviewed, to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.
|
|
Search Alerts/Recalls
|
|